ArticleScientific reports2019

Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion.

Laura M Prolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.